Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
23 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07065344 | A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region(DOMAIN) | recruiting | — | 500 | AstraZenecaINDUSTRY | 10 | Sep 23, 2026 | clinicaltrials |
| NCT07650773 | CHARM Hepatocellular Carcinoma MEA Study | recruiting | — | 4,000 | AstraZenecaINDUSTRY | 7 | Sep 3, 2026 |
| clinicaltrials |
| NCT07766538 | Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait(ALIA) | not yet recruiting | N/A | 500 | Sulaiman KhadadahOTHER_GOV | 1 | Aug 17, 2026 | clinicaltrials |
| NCT03782207 | A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice(IMreal) | completed | — | 2,756 | Hoffmann-La RocheINDUSTRY | 30 | Aug 13, 2026 | clinicaltrials |
| NCT04458831 | A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)(IONA-MM) | completed | — | 583 | SanofiINDUSTRY | 21 | Jul 29, 2026 | clinicaltrials |
| NCT05430971 | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry | recruiting | — | 200 | Immune Oncology Research InstituteOTHER | 15 | Jun 5, 2026 | clinicaltrials |
| NCT06480058 | Predictors of Bariatric Surgery Weight Loss(BariPredict) | completed | — | 376 | Kuwait UniversityOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT03140176 | Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.(OPTIMISE) | terminated | — | 77 | PfizerINDUSTRY | 4 | May 10, 2024 | clinicaltrials |
| NCT05239507 | OREIOS International Study(OREIOS) | completed | — | 1,127 | AstraZenecaINDUSTRY | 11 | Mar 13, 2024 | clinicaltrials |
| NCT04808050 | Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer(THASSOS-INTL) | completed | — | 748 | AstraZenecaINDUSTRY | 7 | Feb 21, 2024 | clinicaltrials |
| NCT04964908 | Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia(CREEK) | completed | — | 1,088 | AstraZenecaINDUSTRY | 17 | Feb 20, 2024 | clinicaltrials |
| NCT03532737 | Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer | unknown | Phase 2 | 50 | Kuwait Cancer Control CenterOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04742192 | Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer(EARLY-EGFR) | completed | — | 601 | AstraZenecaINDUSTRY | 15 | Aug 14, 2023 | clinicaltrials |
| NCT04898374 | Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Kuwait Cancer Control CenterOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT03656965 | EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug | unknown | Phase 3 | 50 | Kuwait Cancer Control CenterOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT02273856 | Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)(NADIR) | terminated | — | 25 | Astellas Pharma International B.V.INDUSTRY | 7 | Jun 21, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
| NCT01081626 | Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction | completed | Phase 4 | 310 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 3 | Feb 13, 2014 | clinicaltrials |
| NCT00944424 | Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca(GORG-002) | unknown | Phase 3 | 260 | King Faisal Specialist Hospital & Research CenterOTHER | 3 | Dec 13, 2011 | clinicaltrials |
Data updated 4 days agoSource updated unknownsource: clinicaltrials